Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.24.1.1.u2
Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Marketable Securities

The following is a description of the valuation methodologies used for assets measured at fair value as of March 31, 2024 and December 31, 2023.

 

Marketable Securities: Valued using quoted prices in active markets for identical assets.

 

    Quoted Prices
in Active
Markets for
Identical Assets
or Liabilities
(Level 1)
    Quoted Prices
for Similar
Assets or
Liabilities in
Active Markets
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
 
Marketable securities at March 31, 2024   $ 1,509,358     $         -     $         -  
                         
Marketable securities at December 31, 2023   $ 2,242,106     $ -     $ -  
Schedule of Fair Value Hierarchy of the Valuation Inputs

        March 31,  
Description   Level   2024  
Liabilities:            
Warrant liabilities (Note 3)   3   $ 7,961,000  
Derivative liabilities (Note 3)   3   $ -  

 

        December 31,  
Description   Level   2023  
Liabilities:            
Warrant liabilities (Note 3)   3   $ 867,000  
Derivative liabilities (Note 3)   3   $ 61,000  
Summary of Change in Fair Value of Warrant Liabilities

The following table sets forth a summary of the change in the fair value of the warrant liabilities that is measured at fair value on a recurring basis for the three months ended March 31, 2024:

 

 

Balance on December 31, 2023   $ 867,000  
Issuance of warrants reported at fair value     -  
Change in fair value of warrant liabilities    

7,064,000

 
Reclassification of warrant liability to equity upon warrant modification     (7,091,000 )
Balance on March 31, 2024   $ -  
Summary of Change in Fair Value of Derivative Liabilities

The following table sets forth a summary of the change in the fair value of the derivative liabilities that is measured at fair value on a recurring basis for the three months ended March 31, 2024:

 

 

Balance on December 31, 2023   $ 61,000  
Issuance of convertible preferred stock with derivative liabilities     -  
Change in fair value of derivative liabilities     (61,000 )
Balance on March 31, 2024   $ -  
Schedule of Estimated Useful Lives of Property Plant and Equipment

The estimated useful lives for the current and comparative periods are as follows:

 

 

    Useful Life
    (in years)
Plant and equipment   5-12
Furniture and fixtures   5-10
Computer equipment & software   3-5
Leasehold Improvements   Shorter of the remaining lease or estimated useful life
Schedule of Estimated Useful Lives of Intangible Assets

Amortization is recognized on a straight-line basis over the estimated useful lives of intangible assets, other than goodwill, from the date that they are available for use. The estimated useful lives for the current and comparative periods are as follows:

    Useful Life
    (in years)
Patents and trademarks   12-17
Schedule of Condensed Consolidated Balance Sheet Information Related to Operating Lease

Lease expense for operating leases consists of the lease payments plus any initial direct costs and is recognized on a straight-line basis over the lease term.

 

The Company’s operating leases are comprised of the 2021 Baltimore Lease and the Platt Street Lease on the Condensed Consolidated Balance Sheets. The information related to these leases are presented below:

Balance Sheet Location   Lease     Lease     Total     Lease     Lease     Total  
    As of March 31, 2024     As of December 31, 2023  
    Platt Street     2021 Baltimore           Platt Street     2021 Baltimore        
Balance Sheet Location   Lease     Lease     Total     Lease     Lease     Total  
Operating Lease                                                
Lease Right of Use   $ -     $ 34,904     $ 34,904     $ -     $ 47,389     $ 47,389  
Lease Payable, current     -       35,981       35,981       -       48,870       48,870  
Lease Payable - net of current     -       -       -       -       -       -  
Schedule of Lease Expense

The following provides details of the Company’s lease expense:

Lease Expenses   Lease     Lease     Total     Lease     Lease     Total  
   

For the Three Months Ended
March 31, 2024

   

For the Three Months Ended
March 31, 2023

 
    Platt Street     2021 Baltimore           Platt Street     2021 Baltimore        
Lease Expenses   Lease     Lease     Total     Lease     Lease     Total  
Operating Leases                                                
Lease Costs   $ -     $ 13,600     $ 13,600     $ 5,660     $ 13,600     $ 19,260  
Schedule of Other Information Related to Leases

Other information as of March 31, 2024 related to leases is presented below:

    Platt Street     2021 Baltimore        
Other Information   Lease     Lease     Total  
Operating Leases                        
Operating cash used   $ -     $ 9,336     $ 9,336  
Average remaining lease term     -       8       8  
Average discount rate     10.0 %     10.0 %     10.0 %
Schedule of Operating Lease Minimum Lease Payments

As of March 31, 2024, the annual minimum lease payments of the Company’s operating lease liabilities were as follows:

    Platt Street     2021 Baltimore        
    Lease     Lease     Total  
For Years Ending December 31,                        
2024            -       36,267       36,267  
Total future minimum lease payments, undiscounted   $ -     $ 36,267     $ 36,267  
Less: Imputed interest     -       286       286  
Present value of future minimum lease payments   $ -     $ 35,981     $ 35,981  
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

As of March 31, 2024 and 2023, the following securities are excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    2024     2023  
    For the Three Months Ended
March 31,
 
    2024     2023  
Stock Options     47,286       145,907  
Unvested Restricted Stock Units     88,668       93169  
Warrants to purchase Common Stock     4,933,622       4,934,106  
Pre-funded Warrants to purchase Common Stock     -       4,505  
Series C Convertible Preferred Warrants     918       918  
Series D Convertible Preferred Stock     1,217       1,217  
Series F Convertible Preferred Stock     1,568,553       4,716,981  
Total potentially dilutive shares     6,640,264       9,896,803